Questions? Chat with the founder on WhatsApp

Chat with the founder on WhatsApp
Arthneeti
HomeRankingsIPOScreenerInstitutions
HomeRankingsIPOScreenerInstitutions
Laxmi Dental LtdQ1 FY27Healthcare Equipment & Supplies
Home/Stocks/Laxmi Dental Ltd/Q1 FY27

Laxmi Dental Ltd Q1 FY27 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹200P/E: 31.4Market Cap: ₹1.1K CrSector: Healthcare Equipment & Supplies

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

Yes

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 3
  • →Laxmi Dental aims to outperform the industry CAGR in the aligner business, targeting exponential growth beyond the current ~30% CAGR through branding, education, and marketing initiatives (Page 14).
  • →The company expects strong growth momentum in aligners supported by training, education, and technology like iScope for at-home monitoring (Page 10).
  • →Domestic dental lab business showed 12% y-o-y growth and the company expects acceleration in growth in upcoming quarters Q2, Q3, and Q4 (Pages 9, 11).
  • →Scanner deployment is planned at 800-1,000 units for the current financial year, with adoption expected to gradually drive growth over the next quarters (Page 11).
  • →Internationally, business grew ~37% including currency tailwinds; strong growth is expected to continue (Page 9).
  • →The company is investing in a new facility to enable operational efficiency and scale capacity to support future growth (Pages 7, 4).

Margin guidance

Category 3
  • →Laxmi Dental aims for revenue growth of 15-20% year-on-year, continuing past performance (Page 12).
  • →EBITDA margin target is maintained at 18-20%, with recent improvement to 19.2% in Q1 FY27 (Page 12).
  • →PAT grew 23.8% y-o-y in Q1 FY27, showing healthy bottom-line growth (Page 4).
  • →Strong aligner business growth (~29% YoY) is expected to continue, supported by branding, training, and patient education initiatives (Page 14).
  • →Domestic lab business growth expected to accelerate beyond current 12% (Page 8).
  • →International business shows robust growth (37.4% YoY), bolstered by favorable currency movements and market expansion (Page 9).
  • →Investment in AI-led automation and new manufacturing facility aims to improve cost-efficiency and scalability, supporting margin expansion (Pages 4, 8).
  • →Long-term optimism about dental industry growth and branding as a key differentiator over next 3-10 years (Page 14).

Fundraise plans

  • →There is no mention of any current or future fundraising through debt or equity in the provided transcript.
  • →The company remains debt-free as noted with a low finance cost of INR 0.3 crores for the quarter.
  • →Management focuses on internal performance improvements, operational efficiencies, and investments through cash flow.
  • →The company is making investments in new machinery, AI-led automation, and a new owned facility to support growth.
  • →There is no indication of plans to raise capital via debt or equity financing in the near future.

Order book

Yes
  • →The transcript does not explicitly mention the current or expected order book or pending orders for Laxmi Dental Limited.
  • →The focus is on strong Q1 FY27 results with highest-ever quarterly revenue, good growth in domestic and international markets, and strategic initiatives.
  • →Management emphasizes controlling performance factors, margin stability, and growth in dental lab and aligner segments.
  • →Scanner deployment expected to be 800-1000 units in the current financial year, indicating ongoing demand pipeline.
  • →International expansion and new CEO hire for the USA business suggest growth intent but no specific order backlog figures shared.
  • →Overall positive outlook but no direct quantitative data on pending orders or order book status provided in the call.

Capex plans

Yes
  • →Laxmi Dental plans to invest in new machinery during FY27 to modernize and expand manufacturing capacity, supporting long-term growth and improving operational efficiencies.
  • →The company has executed a letter of intent to acquire new land in Palghar, Maharashtra, aiming to transition from leased premises to an owned facility to enhance workflow efficiency, cost control, and future scalability.
  • →Plans to let go of two rented factory facilities and move operations to the new facility to eliminate rental costs, with a phased transition to avoid disruptions.
  • →Continued investments in AI-led automation initiatives to improve efficiency and scalability.
  • →Ongoing evaluation and deployment of dental scanners, targeting to deploy about 800 to 1,000 scanners in the current financial year to drive digital dentistry adoption.

Track Laxmi Dental Ltd — get its next earnings analysis in your feed

Margin guidance

Category 3
  • →Laxmi Dental aims for revenue growth of 15-20% year-on-year, continuing past performance (Page 12).
  • →EBITDA margin target is maintained at 18-20%, with recent improvement to 19.2% in Q1 FY27 (Page 12).
  • →PAT grew 23.8% y-o-y in Q1 FY27, showing healthy bottom-line growth (Page 4).
  • →Strong aligner business growth (~29% YoY) is expected to continue, supported by branding, training, and patient education initiatives (Page 14).
  • →Domestic lab business growth expected to accelerate beyond current 12% (Page 8).
  • →International business shows robust growth (37.4% YoY), bolstered by favorable currency movements and market expansion (Page 9).
  • →Investment in AI-led automation and new manufacturing facility aims to improve cost-efficiency and scalability, supporting margin expansion (Pages 4, 8).
  • →Long-term optimism about dental industry growth and branding as a key differentiator over next 3-10 years (Page 14).

Order book

Yes
  • →The transcript does not explicitly mention the current or expected order book or pending orders for Laxmi Dental Limited.
  • →The focus is on strong Q1 FY27 results with highest-ever quarterly revenue, good growth in domestic and international markets, and strategic initiatives.
  • →Management emphasizes controlling performance factors, margin stability, and growth in dental lab and aligner segments.
  • →Scanner deployment expected to be 800-1000 units in the current financial year, indicating ongoing demand pipeline.
  • →International expansion and new CEO hire for the USA business suggest growth intent but no specific order backlog figures shared.
  • →Overall positive outlook but no direct quantitative data on pending orders or order book status provided in the call.

How does Laxmi Dental Ltd rank vs peers in Healthcare Equipment & Supplies?

Pro feature
1Laxmi Dental Ltd
Rev 3Mar 3
2Healthcare Equipment & Supplies Company A
Rev 1Mar 2
3Healthcare Equipment & Supplies Company B
Rev 2Mar 1
4Healthcare Equipment & Supplies Company C
Rev 2Mar 3

See full Healthcare Equipment & Supplies sector rankings

How does Laxmi Dental Ltd rank in Healthcare Equipment & Supplies?

Compare Laxmi Dental Ltd against every Healthcare Equipment & Supplies company (Q1 FY27) on revenue, margins and earnings-call signals.

View Healthcare Equipment & Supplies leaderboard →

Related research

Read the full Q1 FY27 earnings insight — Laxmi Dental Ltd

Other quarters — Laxmi Dental Ltd

Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25

Healthcare Equipment & Supplies peers

Fischer Medical Ventures Ltd · Q2 FY26Poly Medicure · Q1 FY27Prevest Denpro Ltd · Q1 FY27Tarsons Products · Q1 FY27Vaidya Sane · Q2 FY26
Laxmi Dental Ltd full stock analysisHealthcare Equipment & Supplies sectorEarnings call directoryRankings dashboard

Questions about this analysis? Chat directly with the founder — real answers about the research, not a support bot.

WhatsApp the founder

Research team or advisory firm? Get earnings-call intelligence and ranking history as research inputs for your firm.

For Institutions

Arthneeti AI

AI-powered stock analysis from earnings call transcripts. Helping Indian investors make smarter decisions with data-driven insights.

Analysis

  • Stock Rankings
  • Sectors
  • Compare Stocks
  • IPO Dashboard
  • Stock Screener
  • Earnings Call Analysis
  • Stocks Under ₹500
  • Multibaggers

Tools

  • MF Overlap Checker
  • SIP Calculator
  • CAGR Calculator
  • FD vs Equity
  • All Calculators

Resources

  • Blog
  • Weekly Digest
  • Portfolio Analysis
  • Build Portfolio
  • Earnings Calendar
  • Q1 FY27 Earnings Hub

Company

  • Pricing
  • How Our Analysis Works
  • For Institutions
  • Terms of Service
  • Privacy Policy

Compare

  • vs Screener.in
  • vs Trendlyne
  • vs Tickertape
  • vs Moneycontrol Pro
+91 90841 32575 support@arthneeti.com Bengaluru, India

© 2026 Arthneeti AI. All rights reserved.

AI-analyzed data from 1,500+ company earnings calls

Continue your research

What Laxmi Dental Ltd's management said in earlier quarters

  • Q1 FY27 earnings call analysis →
  • Q3 FY26 earnings call analysis →
  • Q1 FY26 earnings call analysis →
  • Q4 FY26 earnings call analysis →

Others in Healthcare Equipment & Supplies this season

  • Tarsons Products (Q2 FY26)

    Plastic labware market is expanding faster than glass, currently at INR1,200 crores, signaling long-term sector growth opportunities. Key concall takeaways…

  • Vaidya Sane (Q2 FY26)

    Ongoing construction and CAPEX of about INR 25-30 crores for capacity expansion at Khopoli and Nagpur hospitals. Key concall takeaways from Vaidya Sane's Q2…

  • Tarsons Products (Q3 FY26)

    Tarsons has undertaken a significant capex of INR 600 crores announced in 2021-22, with partial commercialization in 2026. Key concall takeaways from Tarsons…

  • OSEL Devices Ltd (Q4 FY26)

    PAT growth was 45.7% in FY26; management is optimistic about sustaining or improving profitability and EPS in coming years. Key concall takeaways from OSEL…

Compare:vs Poly Medicurevs Molbio Diagnostics Ltdvs Fischer Medical Ventures Ltd